Oral GLP-1 RA reduces blood glucose and bodyweight among people with type 2 diabetes
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight.
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight.